An early study reported that patients with DM can have lymphocytopenia, manifested as lower peripheral blood CD4+ and CD8+ T-cell and B-cell absolute counts before the initial treatment, and significant increase in lymphocyte count after treatment (16). This evidence concerns the gene CD4 and dermatomyositis.